What's breaking now, across thousands of outlets.
New types of bispecifics, antibod-drug conjugates and cell therapies haven’t yet themselves in the clinic. Pharmaceutical companies are betting billions anyway.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Scientists say new mutation may leave younger people less protected. Just 58 million U.S. adults got a flu shot last season vs 75 million in 2019-20.
For seven days, Caleb Nii Okai pushed through pain, exhaustion and challenging weather to complete a 240-kilometre run from Accra to Kumasi, carrying a message about breast cancer awareness and the…
GMTF Administrator, Regional Minister and stakeholders in a group photograph after the meeting The Administrator of the Ghana Medical Trust Fund (GMTF), popularly known as Mahama Cares, Adjoa Obuobia…
Childhood trauma leaves a physical mark on the brain's structure, but heavy drinking might hide the evidence. A new brain imaging study reveals how alcohol use disorder can overwrite the subtle…
Chris Bahl believes AI can help make tiny proteins capable of doing things that bigger and more traditional proteins like antibodies struggle to do.
Certain viruses attack bacteria and can sometimes clear antibiotic-resistant infections. Researchers said they had tailored a virus to attack one patient’s illness.
